Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm
Briefings in Bioinformatics · 2024
DOI: 10.1093/bib/bbaf042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von Nanhai Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore. Hauptthemen laut MEDLINE: Algorithms, Mutation, Benchmarking, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, Singapore.
Abstract (Originalsprache)
Mutational signatures are characteristic patterns of mutations caused by endogenous mutational processes or by exogenous mutational exposures. There has been little benchmarking of approaches for determining which signatures are present in a sample and estimating the number of mutations due to each signature. This problem is referred to as “signature attribution.” We show that there are often many combinations of signatures that can reconstruct the patterns of mutations in a sample reasonably well, even after encouraging sparse solutions. We benchmarked 13 approaches to signature attribution, including a new approach called Presence Attribute Signature Activity (PASA), on large synthetic data sets (2700 synthetic samples in total). These data sets recapitulated the single-base, insertion–deletion, and doublet-base mutational signature repertoires of nine cancer types. For single-base substitution mutations, PASA and MuSiCal outperformed other approaches on all the cancer types combined. However, the ranking of approaches varied by cancer type. For doublet-base substitutions and small insertions and deletions, while PASA outperformed the other approaches in most of the nine cancer types, the ranking of approaches again varied by cancer type. We believe that this variation reflects inherent difficulties in signature attribution. These difficulties stem from the fact that there are often many attributions that can reasonably explain the pattern of mutations in a sample and from the combinatorial search space due to the need to impose sparsity. Tables herein can provide guidance on the selection of mutational signature attribution approaches that are best suited to particular cancer types and study objectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
- Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, 2424 Erwin Road, Durham, NC 27710, United States.
ORCID-Profile: Nanhai Jiang, Yang Wu, Steven G Rozen
Förderung
- National Medical Research Council, Singapore
Zitieren
APA
Jiang, N., Wu, Y., & Rozen, S. G. (2024). Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf042
Vancouver
Jiang N, Wu Y, Rozen SG. Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbaf042
BibTeX
@article{Jiang2024,
author = {Jiang, Nanhai and Wu, Yang and Rozen, Steven G},
title = {Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm},
journal = {Briefings in Bioinformatics},
year = {2024},
doi = {10.1093/bib/bbaf042}
}
EUVIMED